Alterations of Immune Response of Non-Small Cell Lung Cancer with Azacytidine
www.impactjournals.com/oncotarget/ Oncotarget, November, Vol.4, No 11 Alterations of immune response of non-small cell lung cancer with Azacytidine John Wrangle1*, Wei Wang2*, Alexander Koch3*, Hariharan Easwaran4, Helai P. Mohammad5, Xiaoyu Pan4, Frank Vendetti4, Wim VanCriekinge3, Tim DeMeyer3, Zhengzong Du4, Princy Parsana6, Kristen Rodgers4, Ray-Whay Yen4, Cynthia A. Zahnow4, Janis M. Taube7, Julie R. Brahmer4, Scott S. Tykodi10, Keith Easton10, Richard D. Carvajal11, Peter A. Jones8, Peter W. Laird8, Daniel J. Weisenberger8, Salina Tsai9, Rosalyn A. Juergens4, Suzanne L. Topalian12, Charles M. Rudin4, Malcolm V. Brock4, Drew Pardoll4, and Stephen B. Baylin4 1 The Johns Hopkins University, School of Medicine, Oncology Center-Hematology/Medical Oncology, Baltimore, Maryland 2 The Johns Hopkins University, School of Medicine, Human Genetics Graduate Program, Baltimore, Maryland 3 Departments of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium 4 The Johns Hopkins University, School of Medicine, Oncology, Baltimore, Maryland 5 GlaxoSmithKline Pharmaceuticals, Cancer Epigenetics and Oncology, Collegeville, Pennsylvania 6 The Johns Hopkins University, Advanced Academic Bioinformatics, Baltimore, Maryland 7 The Johns Hopkins University, School of Medicine, Dermatology and Oral Pathology, Baltimore, Maryland 8 USC Epigenome Center, Keck School of Medicine, University of Southern California, Los Angeles, California 9 The Johns Hopkins University, School of Medicine, Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, Maryland 10 University of Washington and Fred Hutchison Cancer Research Center, Seattle Cancer Care Alliance, Seattle, Washington 11 Memorial Sloan-Kettering Cancer Center, New York, New York 12 The Johns Hopkins University, School of Medicine, Surgery, Baltimore, Maryland * These authors contributed equally Correspondence to: Stephen B.
[Show full text]